Logo image
IRO Home Research units Researcher Profiles
Sign in
Management of pharyngoesophageal spasm with Botox
Journal article   Peer reviewed

Management of pharyngoesophageal spasm with Botox

Siew-Shuen Chao, Scott M Graham and Henry T Hoffman
Otolaryngologic clinics of North America, Vol.37(3), pp.559-566
06/2004
DOI: 10.1016/j.otc.2004.01.003
PMID: 15163601

View Online

Abstract

Pharyngoesophageal spasm following laryngectomy can result in failure of tracheoesophageal (TE) speech and dysphagia. Chemical denervation with Clostridium botulinum toxin (Botox) is effective in relieving pharyngeal constrictor spasm, thereby facilitating TE speech production. This article reviews the technique, results,and complications regarding the use of Botox in the management of TE speech failure associated with pharyngoesophageal spasm.
Botulinum Toxins, Type A - therapeutic use Esophageal Spasm, Diffuse - drug therapy Humans Neuromuscular Agents - administration & dosage Deglutition Disorders - etiology Laryngectomy - rehabilitation Speech, Esophageal Neuromuscular Agents - therapeutic use Deglutition Disorders - drug therapy Botulinum Toxins, Type A - administration & dosage Pharyngeal Diseases - drug therapy Patient Selection

Details

Logo image